XML 17 R5.htm IDEA: XBRL DOCUMENT v3.20.2
CONSOLIDATED STATEMENTS OF EQUITY (Unaudited) - USD ($)
Total
Common Stock
Preferred stock
Series A Preferred
Preferred stock
Series C Preferred
Additional Paid-In Capital
Retained Earnings
Non-controlling Interest
Beginning balance at Dec. 31, 2018 $ 28,809,044 $ 40,175 $ 420 $ 0 $ 75,131,122 $ (47,800,886) $ 1,438,213
Beginning balance (in shares) at Dec. 31, 2018   40,174,821 419,859 0      
Increase (Decrease) in Stockholders' Equity              
Share based compensation expense 143,063       143,063    
Conversion of Series B1 Preferred stock to common 150,010 $ 96     149,914    
Conversion of Series B1 Preferred stock to common (in shares)   96,160          
Dividends on Series B and B1 (406,795)         (406,795)  
Accretion of discount on Series B and B1 (560,675)         (560,675)  
Net income (loss) (5,068,995)         (4,963,564) (105,431)
Ending balance (in shares) at Mar. 31, 2019   40,270,981 419,859 0      
Ending balance at Mar. 31, 2019 23,065,652 $ 40,271 $ 420 $ 0 75,424,099 (53,731,920) 1,332,782
Beginning balance at Dec. 31, 2018 28,809,044 $ 40,175 $ 420 $ 0 75,131,122 (47,800,886) 1,438,213
Beginning balance (in shares) at Dec. 31, 2018   40,174,821 419,859 0      
Increase (Decrease) in Stockholders' Equity              
Exercise of options to common (in shares)   75,925          
Net income (loss) (5,698,760)            
Ending balance (in shares) at Jun. 30, 2019   40,346,906 419,859 0      
Ending balance at Jun. 30, 2019 21,380,055 $ 40,347 $ 420 $ 0 75,599,525 (55,105,156) 844,919
Beginning balance at Mar. 31, 2019 23,065,652 $ 40,271 $ 420 $ 0 75,424,099 (53,731,920) 1,332,782
Beginning balance (in shares) at Mar. 31, 2019   40,270,981 419,859 0      
Increase (Decrease) in Stockholders' Equity              
Exercise of options to common 4,500 $ 76     4,424    
Exercise of options to common (in shares)   75,925          
Share based compensation expense 171,002       171,002    
Distribution to noncontrolling (285,534)           (285,534)
Dividends on Series B and B1 (412,875)         (412,875)  
Accretion of discount on Series B and B1 (532,925)         (532,925)  
Net income (loss) (629,765)         (427,436) (202,329)
Ending balance (in shares) at Jun. 30, 2019   40,346,906 419,859 0      
Ending balance at Jun. 30, 2019 21,380,055 $ 40,347 $ 420 $ 0 75,599,525 (55,105,156) 844,919
Beginning balance at Dec. 31, 2019 23,102,026 $ 43,396 $ 420 $ 0 81,527,351 (59,246,514) 777,373
Beginning balance (in shares) at Dec. 31, 2019   43,395,563 419,859 0      
Increase (Decrease) in Stockholders' Equity              
Purchase of shares of consolidated subsidiary (71,171)       (71,171)    
Adjustment of carrying mount of non-controlling interest 9,091,068       9,091,068    
Share based compensation expense 163,269       163,269    
Conversion of Series B1 Preferred stock to common 3,368,474 $ 2,159     3,366,315    
Conversion of Series B1 Preferred stock to common (in shares)   2,159,278          
Dividends on Series B and B1 (344,499)         (344,499)  
Accretion of discount on Series B and B1 (932,003)         (932,003)  
Accretion of redeemable non-controlling interest to redemption value (10,966,349)         (10,966,349)  
Net income (loss) 2,908,128         2,788,860 119,268
Ending balance (in shares) at Mar. 31, 2020   45,554,841 419,859 0      
Ending balance at Mar. 31, 2020 26,318,943 $ 45,555 $ 420 $ 0 94,076,832 (68,700,505) 896,641
Beginning balance at Dec. 31, 2019 23,102,026 $ 43,396 $ 420 $ 0 81,527,351 (59,246,514) 777,373
Beginning balance (in shares) at Dec. 31, 2019   43,395,563 419,859 0      
Increase (Decrease) in Stockholders' Equity              
Purchase of shares of consolidated subsidiary (71,171)            
Adjustment of carrying mount of non-controlling interest 9,091,068            
Net income (loss) (6,498,222)            
Ending balance (in shares) at Jun. 30, 2020   45,554,841 419,859 0      
Ending balance at Jun. 30, 2020 15,178,624 $ 45,555 $ 420 $ 0 94,233,371 (79,979,484) 878,762
Beginning balance at Mar. 31, 2020 26,318,943 $ 45,555 $ 420 $ 0 94,076,832 (68,700,505) 896,641
Beginning balance (in shares) at Mar. 31, 2020   45,554,841 419,859 0      
Increase (Decrease) in Stockholders' Equity              
Share based compensation expense 156,539       156,539    
Dividends on Series B and B1 (360,217)         (360,217)  
Accretion of discount on Series B and B1 (539,235)         (539,235)  
Accretion of redeemable non-controlling interest to redemption value (1,381,889)         (1,381,889)  
Net income (loss) (9,015,517)         (8,997,638) (17,879)
Net income (loss) (8,888,473)            
Ending balance (in shares) at Jun. 30, 2020   45,554,841 419,859 0      
Ending balance at Jun. 30, 2020 $ 15,178,624 $ 45,555 $ 420 $ 0 $ 94,233,371 $ (79,979,484) $ 878,762